Crinetics PharmaceuticalsCRNX

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. R. Scott Struthers, PhD

$3.4B

Market Cap • 24/04/2024

2008

(há 16 anos)
Fundação

2018

(6 years ago)
IPO

NASDAQ

Listagem
Flag of US

San Diego

Sede • California

210

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CRNXSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-0%

1 dia

22/04/2024

-2%

1 semana

17/04/2024

0%

1 mês

25/03/2024

128%

1 ano

24/04/2023

79%

5 anos

24/04/2019

10 anos

Histórico